Work

Abstract 4366419: GLP-1 Receptor Agonist Semaglutide Improves Hepatic Metabolism and Reverses Hepatic Steatosis Independent of Weight Loss in Cardiometabolic HFpEF

Year: 2025

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.152.suppl_3.4366419

Authors: Natalie Gehred, Tatiana Gromova, Mahmoud Elbatreek, Zhen Li, Jingshu Chen, Naoto Muraoka, Martin Borch Jensen, Vinay Kartha, Chris Carrico, Timothy Allerton, Traci Goodchild, David Lefer, Thomas Vondriska

Institutions: University of California, Los Angeles, Cedars-Sinai Medical Center, China Pharmaceutical University, Pennington Biomedical Research Center, Cedars-Sinai Smidt Heart Institute

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415792867

Cites:

Cited by:

Related to: